A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy

This publication has 26 references indexed in Scilit:

• Palladium-103 brachytherapy for prostate carcinoma
  Published by Elsevier ,2000
• The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Isotope selection for patients undergoing prostate brachytherapy
  International Journal of Radiation Oncology*Biology*Physics, 1999
• Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine‐125 interstitial implants
  Medical Physics, 1998
• Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma
  Cancer, 1998
• A Dose–Response Study for I-125 Prostate Implants
  International Journal of Radiation Oncology*Biology*Physics, 1998
• The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy
  Seminars in Surgical Oncology, 1997
• Biochemical disease-free survival following 125I prostate implantation
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Some treatment planning considerations for 103Pd and 125I permanent interstitial implants
  International Journal of Radiation Oncology*Biology*Physics, 1992